Navigation Links
Delivering siRNAs to Difficult Cell Types

y efficient method for transfecting primary and hard-to-transfect cells with siRNAs. This was demonstrated here using five different cell types. The results show that transfection via electroporation provides an efficient nonviral method to induce RNAi in cells that are resistant to siRNA delivery using chemical transfection agents. However, conditions vary with cell type and it is important to optimize siRNA concentration and pulse number to achieve optimal silencing. Delivery of siRNA to primary cell types, a setting where genetic manipulations have traditionally proved difficult, will be a valuable research tool in various applications including gene function analysis, target validation, gene discovery, and even development of gene-specific siRNA-based therapeutics.


Cy is a trademark of Amersham Biosciences.


back to top


Ordering Information
Cat# Product Name Size 8990 siPORT siRNA Electroporation Buffer 12 x 1.5 ml
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Delivering siRNA Using Adenoviral Vectors
2. Silencer Validated siRNAs
3. Cenix-Designed siRNAs for 95% of Human and Mouse Genomes
4. Five Ways to Produce siRNAs
5. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection
6. IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER!
7. Optimizing Chemical Transfection and Electroporation of siRNAs
8. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
9. Deliver siRNAs Into Primary Cells
10. Optimize Transfection of siRNAs for RNAi
11. RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Delivering siRNAs Difficult Cell Types

(Date:11/25/2009)...tCall/--ArdeaBiosciences,Inc.(Nasdaq: RDEA )announ...fexecutiveofficer,willpresentatthePiperJaffray21st...sareasfollows:,PiperJaffray21stAnnualHealthCareCo...EasternTime,Location:TheNewYorkPalaceHotel,NewYork...eye/,target=,_blank,title=,http://www.corporate-i...
(Date:11/24/2009)...investment bank KTA Capital,s client Neuren Pharma...onvertible note private placement with a U.S. inst...nged by KTA Capital as Neuren,s exclusive placemen...w York (PRWEB) November 23, 2009 -- The independen...;KTA Capital") has announced that its client ...
(Date:11/24/2009)...tCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )wil...ember1stat1:45PMGMTinLondon,7:45AMUS/CST.Intereste...netavailableat http://inve s tor.sig m a a ...sthisfile. ,, AboutSigma-Aldrich: Sigma-Aldr...tschemicalandbiochemicalproductsandkitsareusedinsc...
(Date:11/24/2009)...re-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiop...alizingnovelpainmanagementtherapies,announcedtoday...er,isscheduledtopresentatthe21stAnnualPiperJaffray...NewYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTo...eavailabletorespondtoquestionsduringthepresentatio...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
.... 16 Inverness Medical,Innovations, Inc. (Amex: ...d,diagnostic products for the consumer and profess... Chairman, Chief Executive Officer and,President, ...attending the,Goldman Sachs Diagnostics Conference...in order to meet with current and prospective inve...
...ger Nuclease Platform enables Precise, Permanent, ... Genome, ST. LOUIS, Sept. 16 Sigma-Aldrich (Nasd...of zinc finger nuclease (ZFN),reagents. The CompoZ...researchers with the ability to target and precise...g in cell lines or whole organisms with defined,ge...
... Human trials show that Emulin(TM), a plant-...ng Type 2 diabetes medication, at controlling bloo... Winter Haven, FL (PRWEB) September 16, 20... blood sugar levels in Type 2 diabetics better tha...sults of human trials released today., , ,The tria...
Other Biology Technology:Sigma-Aldrich Launches Breakthrough Genome-Editing Tools 2Sigma-Aldrich Launches Breakthrough Genome-Editing Tools 3Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™ 2
(Date:11/24/2009)...p weakened and flabby arteries from collapsing hav...se stents are no longer needed -- once the arterie...ously, doctors had no choice but to leave them in ...ersity,s Department of Biomedical Engineering has ... carries drugs where they,re needed, then dissolve...
(Date:11/24/2009)...es fish food is a matter of debate. A high-profile...ost 50 percent of their carbon from trees and leav...restrial and aquatic ecosystems. , But new resea...s not likely to be true. Algae provide a much rich... to research published this week in the Proceedin...
(Date:11/23/2009)...Mass. November 23, 2009 Applied mathematicians d...ta lancifolia ), a characteristic long leaf with a...ples along the edges. The simple cause of the lily... bending during differential growthwas revealed by...m ribbons. , Haiyi Liang, a postdoctoral student...
Breaking Biology News(10 mins):A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Powerful nutrient cocktail can put kids with Crohns into remission 8860 1Powerful nutrient cocktail can put kids with Crohns into remission 8860 2Building Healthcare Leadership in Africa 3A A Call to Action 49080 1Building Healthcare Leadership in Africa 3A A Call to Action 49080 2Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 1Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 2Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 3Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 4Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 5
... Private Data in Transit from Capture Point Protec... Security , , WALL, N.J., March 26 BIO-key Int...der in finger-based biometric identification and w...S. Patent and Trademark Office has approved the is...e," which covers a simple, yet secure method of pr...
...than previously believed are allergic to the most ...itioners and soap. A thesis presented at the Sahlg...ound that over 5% of those who underwent patch tes... fragrance ingredient linalool. , "I would suspec...en are allergic to air oxidized linalool. That may...
... b3c newswire / -Companies are using MDDexec&rsquo...arketing USA as a platform to launch new products....unity” industry professionals discuss import...ne training all with the aim to overcome pricing p...andi Altschul, the CEO from POP TEST stated on 25/...
Other Biology News:BIO-key(R) Granted Patent for Trusted Biometric Device Security Solution 2BIO-key(R) Granted Patent for Trusted Biometric Device Security Solution 3Common fragrance ingredients in shampoos and conditioners are frequent causes of eczema 2
Rat Anti-Mouse ABCA1 Monoclonal Antibody, Unconjugated, Clone 5A1-1422.11 from ABR-Affinity BioReagents
Rabbit Anti-Human ADAMTS16 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human SART3 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human JAB1 Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: